FDA Inspection 963579 — HCSC-Blood Center

HCSC-Blood Center — FEI 2573135

The FDA completed an inspection of HCSC-Blood Center on March 1, 2016 in Bethlehem, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 1, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bethlehem, PA (United States)